|Day Low/High||50.78 / 52.28|
|52 Wk Low/High||44.62 / 81.68|
Company also receives expanded FDA 510(k) clearance for COALESCE™ Thoracolumbar Interbody Fusion Device and COHERE® Cervical Interbody Fusion Device for multi-level cases from C2-T1
Company expects savings to fuel innovation and growth in spine surgery solutions
- Expands the Company's Position as the Leading Provider of Intraoperative Neurophysiological Monitoring Services with Complementary Geographic Footprint
The most recent short interest data was recently released for the 11/30/2017 settlement date, and Nuvasive Inc is one of the most shorted stocks of the Russell 3000, based on 10.32 "days to cover" versus the median component at 5.11. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.
NuVasive showcases new innovation including XLIF® Crestline™, Lateral ALIF, Modulus™ XLIF, TLX™ system, LessRay® and porous PEEK technology, along with new Advanced Materials Science™ portfolio; Company celebrates 15 years of leading lateral spine surgery with XLIF procedure
NuVasive launches Lateral ALIF, XLIF® Crestline™ and Lateral MAS® Fixation to expand Company's comprehensive lateral portfolio and enable lateral single-position surgery; Company announces Advanced Materials Science™ portfolio designed to deliver the most advanced implant surface design
VIRT, HOG, HBI, NUVA and ATHN all recently were downgraded by TheStreet's Quant Ratings.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: FNWB, GS, LIVE, RMBS Downgrades: BOJA, MJCO, NUVA, WYNN Initiations: SBOW Read on to get TheStreet Quant Ratings' detailed report:
New clearance for TLX™ system includes indications for use with allogeneic bone graft and in additional levels of the spine; Technology to be showcased at NASS 2017
New Additional Clearance for the Company's PRECICE® system includes fracture fixation, pseudoarthrosis, malunions, nonunions and bone transport
Complaint Says Former Vice Chairman and Board Member Schemed for over a Year Prior to Joining Competitor as Executive Chairman in Egregious Breach of Fiduciary Duties and in Violation of His Contractual Obligations
NuVasive brings together surgeons, hospital executives, clinical leaders and policy experts to discuss spine care; former NFL Pro Bowl quarterback Archie Manning delivers keynote address
The Law Firm of Arons & Arons, LLC. has initiated an investigation of NuVasive, Inc.
The most recent short interest data was recently released for the 08/31/2017 settlement date, and Nuvasive Inc is one of the most shorted stocks of the Russell 3000, based on 8.81 "days to cover" versus the median component at 6.19. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.
NuVasive invests in advanced materials science portfolio with first-of-its-kind porous PEEK technology
Latest clearance unites RELINE® Small Stature fixation portfolio with the MAGEC@ System and introduces a new design with 5.0 millimeter rod to be unveiled at Scoliosis Research Society 52nd Annual Meeting
The Company's plans include expansion of state-of-the-art surgeon education lab, creation of a new technology innovation center and extension of work space as talent base grows
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.